Home > Publications database > Gastrointestinal toxicity of gemtuzumab ozogamicin: real-life data from the AMLCG, SAL, and CELL study groups. > print |
001 | 303034 | ||
005 | 20250723114147.0 | ||
024 | 7 | _ | |a 10.1182/bloodadvances.2024014570 |2 doi |
024 | 7 | _ | |a pmid:39993233 |2 pmid |
024 | 7 | _ | |a pmc:PMC12268538 |2 pmc |
024 | 7 | _ | |a 2473-9529 |2 ISSN |
024 | 7 | _ | |a 2473-9537 |2 ISSN |
037 | _ | _ | |a DKFZ-2025-01481 |
041 | _ | _ | |a English |
082 | _ | _ | |a 610 |
100 | 1 | _ | |a Knabe, Ricarda |b 0 |
245 | _ | _ | |a Gastrointestinal toxicity of gemtuzumab ozogamicin: real-life data from the AMLCG, SAL, and CELL study groups. |
260 | _ | _ | |a Washington, DC |c 2025 |b American Society of Hematology |
336 | 7 | _ | |a article |2 DRIVER |
336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1753189393_32229 |2 PUB:(DE-HGF) |
336 | 7 | _ | |a ARTICLE |2 BibTeX |
336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
536 | _ | _ | |a 899 - ohne Topic (POF4-899) |0 G:(DE-HGF)POF4-899 |c POF4-899 |f POF IV |x 0 |
588 | _ | _ | |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de |
700 | 1 | _ | |a Muller, Philippe |0 0009-0000-0985-7666 |b 1 |
700 | 1 | _ | |a Schliemann, Christoph |0 0000-0003-1755-9583 |b 2 |
700 | 1 | _ | |a Hanoun, Maher |0 0000-0002-1754-8940 |b 3 |
700 | 1 | _ | |a Unglaub, Julia Marie |0 0000-0002-3577-5493 |b 4 |
700 | 1 | _ | |a Weinbergerová, Barbora |0 0000-0001-6460-2471 |b 5 |
700 | 1 | _ | |a Mayer, Jiří |b 6 |
700 | 1 | _ | |a Krekeler, Carolin |0 0009-0000-1808-5928 |b 7 |
700 | 1 | _ | |a Krause, Stefan W |0 0000-0002-5259-4651 |b 8 |
700 | 1 | _ | |a Kaufmann, Martin |b 9 |
700 | 1 | _ | |a Kraus, Sabrina |0 0000-0001-8954-4220 |b 10 |
700 | 1 | _ | |a Steffen, Björn |b 11 |
700 | 1 | _ | |a Modemann, Franziska |0 0000-0002-5897-3310 |b 12 |
700 | 1 | _ | |a Subklewe, Marion |0 0000-0001-9154-9469 |b 13 |
700 | 1 | _ | |a Bücklein, Veit |0 0000-0001-7391-7280 |b 14 |
700 | 1 | _ | |a Kunz, Wolfgang G |0 0000-0002-5021-1952 |b 15 |
700 | 1 | _ | |a Rudelius, Martina |0 0000-0001-6928-9955 |b 16 |
700 | 1 | _ | |a von Bergwelt-Baildon, Michael |0 0000-0002-1952-052X |b 17 |
700 | 1 | _ | |a Gutmair, Katja |0 0009-0002-3948-6186 |b 18 |
700 | 1 | _ | |a Hoster, Eva |0 0000-0002-0749-1389 |b 19 |
700 | 1 | _ | |a Herold, Tobias |0 0000-0002-9615-9432 |b 20 |
700 | 1 | _ | |a Röllig, Christoph |0 0000-0002-3791-0548 |b 21 |
700 | 1 | _ | |a Spiekermann, Karsten |0 P:(DE-He78)b644c56548aced1dd9cf0e858ff30f85 |b 22 |
773 | _ | _ | |a 10.1182/bloodadvances.2024014570 |g Vol. 9, no. 13, p. 3336 - 3339 |0 PERI:(DE-600)2876449-3 |n 13 |p 3336 - 3339 |t Blood advances |v 9 |y 2025 |x 2473-9529 |
909 | C | O | |o oai:inrepo02.dkfz.de:303034 |p VDB |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 13 |6 0000-0001-9154-9469 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 17 |6 0000-0002-1952-052X |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 22 |6 P:(DE-He78)b644c56548aced1dd9cf0e858ff30f85 |
913 | 1 | _ | |a DE-HGF |b Programmungebundene Forschung |l ohne Programm |1 G:(DE-HGF)POF4-890 |0 G:(DE-HGF)POF4-899 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-800 |4 G:(DE-HGF)POF |v ohne Topic |x 0 |
914 | 1 | _ | |y 2025 |
915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b BLOOD ADV : 2022 |d 2024-12-16 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2024-12-16 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2024-12-16 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0501 |2 StatID |b DOAJ Seal |d 2024-07-05T12:07:28Z |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0500 |2 StatID |b DOAJ |d 2024-07-05T12:07:28Z |
915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b DOAJ : Anonymous peer review |d 2024-07-05T12:07:28Z |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2024-12-16 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |d 2024-12-16 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2024-12-16 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |d 2024-12-16 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1190 |2 StatID |b Biological Abstracts |d 2024-12-16 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1110 |2 StatID |b Current Contents - Clinical Medicine |d 2024-12-16 |
915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2024-12-16 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2024-12-16 |
915 | _ | _ | |a IF >= 5 |0 StatID:(DE-HGF)9905 |2 StatID |b BLOOD ADV : 2022 |d 2024-12-16 |
915 | _ | _ | |a Article Processing Charges |0 StatID:(DE-HGF)0561 |2 StatID |d 2024-12-16 |
915 | _ | _ | |a Fees |0 StatID:(DE-HGF)0700 |2 StatID |d 2024-12-16 |
920 | 1 | _ | |0 I:(DE-He78)MU01-20160331 |k MU01 |l DKTK Koordinierungsstelle München |x 0 |
980 | _ | _ | |a journal |
980 | _ | _ | |a VDB |
980 | _ | _ | |a I:(DE-He78)MU01-20160331 |
980 | _ | _ | |a UNRESTRICTED |
Library | Collection | CLSMajor | CLSMinor | Language | Author |
---|